Status:
COMPLETED
An Observational, Cross Sectional Study to Assess the Prevalence of Chronic Kidney Disease (CKD) in Type 2 Diabetes Patients
Lead Sponsor:
AstraZeneca
Conditions:
Diabetes
Eligibility:
All Genders
Brief Summary
This non-interventional, multi-centric, cross-sectional study is aimed to determine the prevalence of Chronic Kidney Disease in Indian patients with Type 2 Diabetes (T2DM). 3000 patients will be enrol...
Detailed Description
This is an observational, multicenter, cross-sectional study to be conducted at 30 sites in India. Endocrinologist/ Diabetologist from multiple private clinics will evaluate the Type 2 Diabetes patien...
Eligibility Criteria
Inclusion
- Known cases of T2DM.
- Male and female patients aged 18 years and above.
- Must provide written Informed consent.
Exclusion
- Patients with known type-1 diabetes.
- Patients with any form of acute kidney injury based on investigator's discretion.
- Patients on maintenance dialysis or known renal transplant patients.
- Patients who have participated in any interventional study within past 3 months prior to entry in this study.
- Pregnant women.
- Patients with symptomatic Urinary Tract Infection (UTI) or with history of hematuria.
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT02208921
Start Date
September 1 2014
End Date
May 1 2015
Last Update
March 25 2016
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Ahmedabad, India
2
Research Site
Bangalore, India
3
Research Site
Chandigarh, India
4
Research Site
Chennai, India